A leader in precision drugs targeting the tumor-stroma-immune interface.

iOnctura is a clinical stage biopharmaceutical company dedicated to delivering innovative cancer treatments to patients with unmet medical need.

iOnctura is uncovering the key to unlock difficult to treat tumors burdened by stroma and immune mediated resistance. We do this by interrogating new mechanisms that disrupt the dynamic interplay at the heart of the tumor-stroma-immune interface.


Latest News